161 related articles for article (PubMed ID: 11345055)
1. Does the availability of a neuraminidase inhibitor impair influenza vaccination? A report from Austria.
Kunze U; Groman E; Vymazal K; Hartl HK
Vaccine; 2001 Feb; 19(15-16):1854. PubMed ID: 11345055
[No Abstract] [Full Text] [Related]
2. Zanamivir. A potent and selective inhibitor of influenza A and B viruses.
Aoki FY; Hayden FG
Clin Pharmacokinet; 1999; 36 Suppl 1():v-ix. PubMed ID: 10429834
[No Abstract] [Full Text] [Related]
3. Zanamivir: from drug design to the clinic.
Elliott M
Philos Trans R Soc Lond B Biol Sci; 2001 Dec; 356(1416):1885-93. PubMed ID: 11779388
[TBL] [Abstract][Full Text] [Related]
4. Position statement: global neuraminidase inhibitor susceptibility network.
Zambon M; Hayden FG;
Antiviral Res; 2001 Mar; 49(3):147-56. PubMed ID: 11428241
[No Abstract] [Full Text] [Related]
5. Influenza virus sialidase: a target for drug discovery.
Kiefel MJ; von Itzstein M
Prog Med Chem; 1999; 36():1-28. PubMed ID: 10818670
[No Abstract] [Full Text] [Related]
6. Surveillance for neuraminidase inhibitor resistance in human influenza viruses from Australia.
Hurt AC; Barr IG; Durrant CJ; Shaw RP; Sjogren HM; Hampson AW
Commun Dis Intell Q Rep; 2003; 27(4):542-7. PubMed ID: 15508516
[TBL] [Abstract][Full Text] [Related]
7. Resistance of influenza viruses to neuraminidase inhibitors--a review.
McKimm-Breschkin JL
Antiviral Res; 2000 Jul; 47(1):1-17. PubMed ID: 10930642
[No Abstract] [Full Text] [Related]
8. Highly potent and long-acting trimeric and tetrameric inhibitors of influenza virus neuraminidase.
Watson KG; Cameron R; Fenton RJ; Gower D; Hamilton S; Jin B; Krippner GY; Luttick A; McConnell D; MacDonald SJ; Mason AM; Nguyen V; Tucker SP; Wu WY
Bioorg Med Chem Lett; 2004 Mar; 14(6):1589-92. PubMed ID: 15006410
[TBL] [Abstract][Full Text] [Related]
9. Progress treating, preventing influenza.
Stephenson J
JAMA; 1998 Nov; 280(20):1729-30. PubMed ID: 9842933
[No Abstract] [Full Text] [Related]
10. Relenza.
McCauley J
Curr Biol; 1999 Nov; 9(21):R796. PubMed ID: 10556097
[No Abstract] [Full Text] [Related]
11. [Neuraminidase inhibitor, anti-influenzal agent--mechanism of action, and how to use clinically].
Kaji M
Nihon Rinsho; 2003 Nov; 61(11):1975-9. PubMed ID: 14619441
[TBL] [Abstract][Full Text] [Related]
12. Neuraminidase inhibitors as antivirals.
Colman PM
Vaccine; 2002 May; 20 Suppl 2():S55-8. PubMed ID: 12110259
[TBL] [Abstract][Full Text] [Related]
13. Advances in pharmacology. New treatments for influenza: neuraminidase inhibitors.
Cross J; Wedekind CA
Med Health R I; 2001 Jun; 84(6):209-11. PubMed ID: 11434154
[No Abstract] [Full Text] [Related]
14. Neuraminidase inhibitors as potential anti-influenza drugs.
Bamford MJ
J Enzyme Inhib; 1996; 10(1):1-16. PubMed ID: 8835926
[No Abstract] [Full Text] [Related]
15. [Oral neuraminidase inhibitor and an early warning system. New weapons against influenza].
Lange W; Vogel GE
MMW Fortschr Med; 2003 Jan; 145(3-4):36-7. PubMed ID: 12619232
[No Abstract] [Full Text] [Related]
16. [Neuraminidase inhibitors against influenza].
Med Monatsschr Pharm; 1999 Sep; 22(9):262-4. PubMed ID: 10536414
[No Abstract] [Full Text] [Related]
17. Neuraminidase inhibitors for influenza.
Moscona A
N Engl J Med; 2005 Sep; 353(13):1363-73. PubMed ID: 16192481
[No Abstract] [Full Text] [Related]
18. Surveillance of influenza isolates for susceptibility to neuraminidase inhibitors during the 2000-2002 influenza seasons.
Mungall BA; Xu X; Klimov A
Virus Res; 2004 Jul; 103(1-2):195-7. PubMed ID: 15163509
[TBL] [Abstract][Full Text] [Related]
19. [Influenza].
Sugaya N
Nihon Rinsho; 2003 Feb; 61 Suppl 2():135-40. PubMed ID: 12722202
[No Abstract] [Full Text] [Related]
20. [New diagnostic possibilities and medications. Fit for influenza?].
Wutzler P
MMW Fortschr Med; 2002 Nov; 144(48):18. PubMed ID: 12532540
[No Abstract] [Full Text] [Related]
[Next] [New Search]
